Application segmentation of the Transcutaneous Electrical Nerve Stimulation (TENS) Unit Electrical Stimulation Pads market delineates four primary use‑cases: pain management, rehabilitation, sports medicine, and neurological disorders. Pain management, encompassing chronic low‑back pain, osteoarthritis and postoperative analgesia, accounts for roughly 45 % of total revenue, driven by the aging population and rising preference for non‑opioid therapies. Rehabilitation applications, such as post‑stroke motor recovery and physiotherapy‑assisted muscle re‑education, represent about 30 % of the market, reflecting expanding outpatient rehab services. Sports medicine, targeting acute injury mitigation and performance enhancement, contributes near 15 %, fueled by increasing participation in high‑intensity activities and athlete‑driven adoption. Neurological disorder applications, including multiple sclerosis spasticity control and peripheral neuropathy pain relief, hold the remaining 10 %, supported by growing clinical evidence and reimbursement pathways. The distribution of these segments is illustrated in the accompanying pie chart, underscoring how each application drives the overall market size within the Transcutaneous Electrical Nerve Stimulation (TENS) Unit Electrical Stimulation Pads segmentation framework.